| CIM11 |
2A83.5 |
Monoclonal immunoglobulin deposition disease
|
|
| CIM11 |
2A83.50 |
Heavy chain deposition disease
|
|
| CIM11 |
2A83.51 |
Light and heavy chain deposition disease
|
|
| CIM11 |
2A83.52 |
Light chain deposition disease
|
|
| CIM11 |
2A84 |
Heavy chain diseases or malignant immunoproliferative diseases
|
|
| CIM11 |
2A84.0 |
Alpha heavy chain disease
|
|
| CIM11 |
2A84.1 |
Gamma heavy chain disease
|
|
| CIM11 |
2A84.2 |
Mu heavy chain disease
|
|
| CIM11 |
2A85 |
Other specified mature B-cell neoplasms or lymphoma
|
|
| CIM11 |
2A85.0 |
Nodal marginal zone lymphoma
|
|
| CIM11 |
2A85.1 |
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach
|
|
| CIM11 |
2A85.2 |
Extranodal marginal zone B-cell lymphoma, primary site skin
|
|
| CIM11 |
2A85.3 |
Extranodal marginal zone B-cell lymphoma, primary site excluding stomach or skin
|
|
| CIM11 |
2A85.4 |
Lymphoplasmacytic lymphoma
|
|
| CIM11 |
2A85.5 |
Mantle cell lymphoma
|
|
| CIM11 |
2A85.6 |
Burkitt lymphoma including Burkitt leukaemia
|
|
| CIM11 |
2A86 |
B-cell lymphoma, mixed features
|
|
| CIM11 |
2A86.0 |
Malignant lymphoma of B cell type, not elsewhere classified
|
|
| CIM11 |
2A86.1 |
B-cell lymphoma unclassifiable with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma
|
|
| CIM11 |
2A86.2 |
B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma
|
|
| CIM11 |
2A90 |
Mature T-cell lymphoma, specified types, nodal or systemic
|
|
| CIM11 |
2A90.0 |
T-cell prolymphocytic leukaemia
|
|
| CIM11 |
2A90.1 |
T-cell large granular lymphocytic leukaemia
|
|
| CIM11 |
2A90.2 |
Chronic lymphoproliferative disorders of NK-cells
|
|
| CIM11 |
2A90.3 |
Aggressive NK cell leukaemia
|
|
| CIM11 |
2A90.4 |
Systemic Epstein-Barr Virus-positive T-cell lymphoma of childhood
|
|
| CIM11 |
2A90.5 |
Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associated
|
|
| CIM11 |
2A90.6 |
Extranodal NK/T-cell lymphoma, nasal type
|
|
| CIM11 |
2A90.7 |
Enteropathy associated T-cell lymphoma
|
|
| CIM11 |
2A90.8 |
Hepatosplenic T-cell lymphoma
|
|
| CIM11 |
2A90.9 |
Angioimmunoblastic T-cell lymphoma
|
|
| CIM11 |
2A90.A |
Anaplastic large cell lymphoma, ALK-positive
|
|
| CIM11 |
2A90.B |
Anaplastic large cell lymphoma, ALK-negative
|
|
| CIM11 |
2A90.C |
Peripheral T-cell lymphoma, not otherwise specified
|
|
| CIM11 |
2B00 |
Subcutaneous panniculitis-like T-cell lymphoma
|
|
| CIM11 |
2B01 |
Mycosis fungoides
|
|
| CIM11 |
2B02 |
Sézary syndrome
|
|
| CIM11 |
2B03 |
Primary cutaneous CD30-positive T-cell lymphoproliferative disorders
|
|
| CIM11 |
2B03.0 |
Primary cutaneous CD30-positive anaplastic large cell lymphoma
|
|
| CIM11 |
2B03.1 |
Lymphomatoid papulosis
|
|
| CIM11 |
2B30 |
Hodgkin lymphoma
|
|
| CIM11 |
2B30.0 |
Nodular lymphocyte predominant Hodgkin lymphoma
|
|
| CIM11 |
2B30.1 |
Classical Hodgkin lymphoma
|
|
| CIM11 |
2B30.10 |
Nodular sclerosis classical Hodgkin lymphoma
|
|
| CIM11 |
2B30.11 |
Lymphocyte-rich classical Hodgkin lymphoma
|
|
| CIM11 |
2B30.12 |
Mixed cellularity classical Hodgkin lymphoma
|
|
| CIM11 |
2B30.13 |
Lymphocyte depleted classical Hodgkin lymphoma
|
|
| CIM11 |
2B31 |
Histiocytic or dendritic cell neoplasms
|
|
| CIM11 |
2B31.0 |
Juvenile xanthogranuloma
|
|
| CIM11 |
2B31.1 |
Histiocytic sarcoma
|
|